Nevada Bill Could Remove Marijuana From Controlled Substances & Strip Pharmacy Board’s Control Over It

February 7, 2023 · Benzinga

New legislation in Nevada seeks to remove the status of cannabis as a “controlled substance” and strip the Nevada Board of Pharmacy of authority over the plant and its derivatives.

Assemblyman Reuben D’Silva said that under the proposed bill, the Cannabis Compliance Board would have oversight over marijuana, reported Fox 5 Vegas.

“We don’t need to have several levels of regulation on a substance now that we know is part and parcel of our community and part and parcel of our economy,” D’Silva said. “In the end, this is a burdensome regulation, and we need to remove the Nevada Board of Pharmacy statutorily now from having oversight over cannabis products and cannabis derivatives.”

Interestingly, in October a Nevada judge stripped the Board of Pharmacy of the ability to regulate cannabis on the heels of months-long litigation over its Scheduled 1 drug designation in the state.

The final ruling by Judge Joe Hardy came weeks after a Clark County District Court judge weighed in on a closely-followed lawsuit filed against the Nevada Board of Pharmacy by the American Civil Liberties Union determining that the listing of cannabis as a Schedule 1 drug is against the state’s constitution.

The judge said that the board had “acted outside of its authority when it failed to remove cannabis from the list of Schedule I substances” even though voters amended the state constitution to legalize medical marijuana.

Nevada legalized medical marijuana use in 2000, followed by another ballot in 2017 that legalized recreational cannabis sale and use.

“If the [pharmacy] board designates a substance as a ‘controlled substance,’ but the designation falls outside the authority delegated by the ​​Legislature, the designation is invalid,” according to the ruling. (Full Story)

In category:Business
Next Post

Cannabis chain once worth $1.7 billion and called the ‘Apple store of weed’ is now nearly failing as the once-hot pot industry faces a major reckoning

A chain of cannabis stores that was once described as the “Apple store of weed” and valued as high as $1.7 billion as a public company, is near financial collapse, according to a regulatory filing. The company, MedMen, said that it has…
Read
Previous Post

Elon Musk Tweets A Simple Yet Powerful Pro-Marijuana Message, Reaches Millions Around The World

One of the most influential CEOs in the world whose statements alone managed to move the needle and create a change has once again expressed his unambiguous support for cannabis. This time, with just three numbers Elon Musk promoted marijuana for free, reported TheStreet. His…
Read
Random Post

American Workers Need to be Protected for Cannabis Use

Punching a clock is just part of daily life for most of us poor schlubs. We get up at the crack of dawn, drag ourselves to whatever is our chosen craft and spend the day grinding away to make ends…
Read
Random Post

California Lawmaker Cautions That Senate-Passed Psychedelics Legalization Bill Faces ‘Challenging Road’ In Assembly

A California Senate-passed bill to legalize the possession of certain psychedelics and facilitated use of the substances is up against a “challenging road” toward passage in the Assembly, the sponsor said on Wednesday. At a virtual event hosted by the Psychedelic and…
Read
Random Post

Maryland Gov. Signs Cannabis Legalization Bill

Maryland Gov. Wes Moore (D) on Wednesday signed the bill to legalize cannabis in the state, Maryland Matters reports. After signing the legislation Moore said it will “ensure that the rollout of recreational cannabis in our state drives opportunity in an equitable…
Read
Random Post

Novel Combination Of Cannabis-Like Compound With Classical Psychedelics Searches IP Coverage In US

Israeli-based next-gen psychedelics biotech Clearmind Medicine  CMND+0.83%+ Free Alerts together with partner clinical-stage pharma company SciSparc SPRC-0.44%+ Free Alerts has filed three provisional patent applications with the United States Patent and Trademark Office (USPTO). The patents cover psychedelic-based therapeutics, including monotherapy and novel combinations…
Read